International Supply Chains in Pharmaceutical Industry After Sars-cov-2

• Autorzy: Katarzyna Witczyńska
• Języki publikacji: EN

Abstrakty

EN

Purpose: The paper presents the issues related to international supply chain in the pharmaceutical industry. Design/methodology/approach: The study used world-bank reports from Statista portal and the own research. Findings: The international supply chain is a sequence of events, a process of moving goods with a goal of meeting the demand for certain products. The simplest chain can be defined by three components: supplier, enterprise, recipient. Due to the coronavirus pandemic, the supply chain has been interrupted and disrupted, as shown by the example of a company from the pharmaceutical industry. Components are sourced from suppliers around the world, and thus that the company and its production cycle do not has been disturbed, schedule timely deliveries. Unfortunately, due to the outbreak of the coronavirus pandemic, timeliness has been disrupted, which means that companies relying on one supplier had to acquire new ones in order to be able to implement production plans and meet deadlines from orders. On the example of a company from the pharmaceutical industry, one can come to the conclusion that through the pandemic in the logistics chain, the following were most affected: fluidity of deliveries, compliance of notifications, disturbances in production planning, execution of orders in accordance with the schedule. The article is theoretical and overview in nature. It uses content analysis and identifies specific analytical categories such as supply chains in pharmaceutical industry and trends in the international trade. The research methodology uses the literature analysis and critique method, as well as the document research and case study method. Originality/value: The publication presents the results of research conducted on the basis the Statista portal. (original abstract)

Słowa kluczowe

EN

Supply chain; Severe Acute Respiratory Syndrome (SARS); COVID-19; Pharmaceutical industry

PL

Łańcuch dostaw; Zespół ostrej ciężkiej niewydolności oddechowej (SARS); COVID-19; Przemysł farmaceutyczny

• Czasopismo: Zeszyty Naukowe. Organizacja i Zarządzanie / Politechnika Śląska
• Rocznik: 2023
• Numer: z. 186 W kierunku przyszłości zarządzania
• Strony: 677--685

Twórcy

autor

Katarzyna Witczyńska

• Wroclaw University, Poland

Bibliografia

• 1. Christopher, M. (2021). Logistics, The Strategie Issues. London: Chapman and Hali.
• 2. Employment (2023). Retrieved from: https://www.oecd.org/employment/, 10.09.2023.
• 3. Heskett, J. Logistyka. Warszawa: PWE.
• 4. Jahre, M., Costes, F. (2008). Supply chain integration and performance: a review of the evidence. The International Journal of Logistics Management.
• 5. Liber, J. (2006). RFID w globalnym łańcuchu dostaw. Eurologistics, nr 1.
• 6. OECD Policy Responses to Coronavirus (COVID-19) Food Supply Chains and COVID-19: Impacts and Policy Lessons (2020). Retrieved from: http://www.oecd.org/coronavirus/ policy-responses/food-supply-chains-and-covid-19-impacts-and-policy-lessons-71b57aea/

Identyfikatory

DOI

10.29119/1641-3466.2023.186.47